A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a blinded, placebo controlled, cross-over trial evaluating the safety of two dose-levels of ARD-501 in subjects with ASD.
Epistemonikos ID: b1e5ad499e6ebf8410d7a4152a607f3acb84b183
First added on: May 15, 2024